Research and Innovation Highlights
What are the many scientists at Bayer actually working on??research, the Bayer Scientific Magazine, offers an insight into the company’s work in the Life Sciences, with a wealth of information on topics relating to health care and nutrition for humans and plants. Scientific innovations from the fields of medicine and agriculture are presented concisely and vividly in the magazine and have also been optimized for every device format, thanks to multimedia articles that automatically adjust to the size of your screen. Even complex matters such as issues pertaining to cancer research or integrated crop protection are made accessible by more than 30 infographics which can be downloaded free of charge.
A balanced diet has an effect on both the body and the brain. But a lot of people do not manage to get enough of the right foods in their daily diet and fail to meet the minimum daily requirements for many vital micronutrients. Nutritional supplements can help in such situations.
Treating illnesses with leaves, flowers and roots: modern phytotherapy originated from the natural therapies practiced for thousands of years. Today, good plant-based medicines are based on exact scientific practices.
Dr. Hans-Georg Lerchen and his colleagues in Wuppertal, Berlin and Cologne are developing new drugs to treat cancer, the -second most common cause of mortality in humans. These antibody-drug conjugates could make chemotherapy more -tolerable for patients.?
It is many scientists’ new favorite tool: optogenetics, a relatively recent discipline that makes it possible to control cells with light signals. Bayer researchers want to use it to improve substance screening and to discover active substances that might otherwise never have been found.
Hemophilia A is a hereditary disease caused by a defect in an extensively studied gene. The disease is therefore particularly well suited for gene therapy, i.e. targeted intervention in the genome of human cells. Bayer experts are working on ways of treating or even curing the disease with gene therapy.
Invasive plants like cheatgrass, which originated in Europe and Asia, are spreading in the United States. As they grow faster than native species, they are displacing them and suppressing the endemic flora. A Bayer herbicide could help to improve the control of those invasive species while leaving native plants unscathed.
For millions of years, plants and bacteria have coexisted in soil in a symbiosis from which both benefit. Bayer researchers have now optimized bacteria in such a way that they stimulate growth better than ever before.
The small hive beetle is a species that is endemic to Sub-Saharan Africa but is currently threatening bee colonies in many regions of the world. What’s more, bees living outside its original distribution area are more susceptible to this threat. How can scientists and beekeepers stop this still relatively unknown pest?
Since December 2016, trainee teachers from Halle have been visiting classes of refugees in Saxony-Anhalt for lessons in a converted caravan. A specially developed project week on the human body is helping refugee children explore scientific methods while also improving their language skills.
Using antivenom to treat snakebites is a balancing act: if a patient doesn’t have venom in his blood after all, the side effects of the antivenom can cause severe damage. But if a bite is left untreated for too long, the antivenom may no longer be of any help.?
When it comes to patient data, most people think of blood counts, biopsies and analyses. However, particularly in developing countries, it can often be much more important for health professionals to know a child’s weight, for example.?
The Bisa Health Application connects patients with doctors – without having to meet in person. Patients receive initial diagnoses and information about diseases directly on their smartphones. 2016 the innovation made it into the final of the Aspirin Social Innovation Award.?
Treatment of cancer is usually a lengthy process. Even if the patient responds well to a treatment, most medicines nevertheless frequently have side effects in the long run. Biochemist Henriette Stoy from the Karolinska Institute in Sweden searched for a new treatment method to make treatments more tolerable for patients.
The livelihoods of many Indian small-holders are under threat. These farmers have financial difficulties because they have to invest most of their profits in machines and labor to stand a chance of harvesting anything at all. Kamal Kisan’s efforts to address this problem earned it the Aspirin Social Innovation Award in 2016.